ArticleJournal for immunotherapy of cancer2023

PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.

Paul Koller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.